Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.90%
#2 Audiera Audiera +14.48%
#3 Ocean Protocol Ocean Protocol +7.13%
#4 The Bitcoin Bull The Bitcoin Bull +6.56%
#5 Rollbit Coin Rollbit Coin +6.44%
#6 Quack AI Quack AI +6.10%
#7 Wiki Cat Wiki Cat +4.88%
#8 HOME HOME +4.55%
#9 Tutorial Tutorial +4.09%
#10 RaveDAO RaveDAO +4.05%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Rangering i aksjer #33981
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Aksjekurs
$0.5762
Markedsverdi
$6.44M
Endring (1 dag)
-23.74%
Endring (1 år)
-56.68%
Land
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategori

Healthcare
Aksjeprishistorikk for Citius Pharmaceuticals, Inc. (CTXR)
Høyeste sluttskurs: $0.69 den 2026-08-01

Laveste sluttskurs: $374.99 den 2014-10-01
Aksjeprishistorikk for Citius Pharmaceuticals, Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $110.31 -37.39%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 12.02%
BE